These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 34894821)

  • 1. A reference tissue forward model for improved PET accuracy using within-scan displacement studies.
    Mandeville JB; Levine MA; Arsenault JT; Vanduffel W; Rosen BR; Sander CY
    J Cereb Blood Flow Metab; 2022 Jun; 42(6):1007-1019. PubMed ID: 34894821
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetic Modelling and Test-Retest Reproducibility for the Dopamine D
    Bertoglio D; Verhaeghe J; Miranda A; Wyffels L; Stroobants S; Dominguez C; Munoz-Sanjuan I; Skinbjerg M; Liu L; Staelens S
    Mol Imaging Biol; 2021 Apr; 23(2):208-219. PubMed ID: 33179158
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rostrocaudal gradients of dopamine D2/3 receptor binding in striatal subregions measured with [(11)C]raclopride and high-resolution positron emission tomography.
    Alakurtti K; Johansson JJ; Tuokkola T; Någren K; Rinne JO
    Neuroimage; 2013 Nov; 82():252-9. PubMed ID: 23727314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative evaluation of changes in binding potential with a simplified reference tissue model and multiple injections of [11C]raclopride.
    Ikoma Y; Watabe H; Hayashi T; Miyake Y; Teramoto N; Minato K; Iida H
    Neuroimage; 2009 Oct; 47(4):1639-48. PubMed ID: 19520172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Test-retest variability of [¹¹C]raclopride-binding potential in nontreatment-seeking alcoholics.
    Yoder KK; Albrecht DS; Kareken DA; Federici LM; Perry KM; Patton EA; Zheng QH; Mock BH; O'Connor S; Herring CM
    Synapse; 2011 Jul; 65(7):553-61. PubMed ID: 20963816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantification of 18F-JNJ-42259152, a novel phosphodiesterase 10A PET tracer: kinetic modeling and test-retest study in human brain.
    Van Laere K; Ahmad RU; Hudyana H; Dubois K; Schmidt ME; Celen S; Bormans G; Koole M
    J Nucl Med; 2013 Aug; 54(8):1285-93. PubMed ID: 23843566
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preclinical Evaluation and Quantification of
    Khanapur S; van Waarde A; Dierckx RA; Elsinga PH; Koole MJ
    J Nucl Med; 2017 Mar; 58(3):466-472. PubMed ID: 27789720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-invasive assessment of distribution volume ratios and binding potential: tissue heterogeneity and interindividually averaged time-activity curves.
    Reimold M; Mueller-Schauenburg W; Becker GA; Reischl G; Dohmen BM; Bares R
    Eur J Nucl Med Mol Imaging; 2004 Apr; 31(4):564-77. PubMed ID: 14689241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantification of aromatase binding in the female human brain using [
    Jonasson M; Nordeman P; Eriksson J; Wilking H; Wikström J; Takahashi K; Niwa T; Hosoya T; Watanabe Y; Antoni G; Sundström Poromaa I; Lubberink M; Comasco E
    J Neurosci Res; 2020 Nov; 98(11):2208-2218. PubMed ID: 32761874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Validation of parametric methods for [¹¹C]PE2I positron emission tomography.
    Jonasson M; Appel L; Engman J; Frick A; Nyholm D; Askmark H; Danfors T; Sörensen J; Furmark T; Lubberink M
    Neuroimage; 2013 Jul; 74():172-8. PubMed ID: 23435214
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticostriatal and Dopaminergic Response to Beer Flavor with Both fMRI and [(11) C]raclopride Positron Emission Tomography.
    Oberlin BG; Dzemidzic M; Harezlak J; Kudela MA; Tran SM; Soeurt CM; Yoder KK; Kareken DA
    Alcohol Clin Exp Res; 2016 Sep; 40(9):1865-73. PubMed ID: 27459715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preclinical Evaluation of 18F-PF-05270430, a Novel PET Radioligand for the Phosphodiesterase 2A Enzyme.
    Chen L; Nabulsi N; Naganawa M; Zasadny K; Skaddan MB; Zhang L; Najafzadeh S; Lin SF; Helal CJ; Boyden TL; Chang C; Ropchan J; Carson RE; Villalobos A; Huang Y
    J Nucl Med; 2016 Sep; 57(9):1448-53. PubMed ID: 27199356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A regularized full reference tissue model for PET neuroreceptor mapping.
    Mandeville JB; Sander CYM; Wey HY; Hooker JM; Hansen HD; Svarer C; Knudsen GM; Rosen BR
    Neuroimage; 2016 Oct; 139():405-414. PubMed ID: 27364474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The simplified reference tissue model for SPECT/PET brain receptor studies. Interpretation of its parameters.
    Buchert R; Thiele F
    Nuklearmedizin; 2008; 47(4):167-74. PubMed ID: 18690377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dual time-point imaging for post-dose binding potential estimation applied to a [
    Lopes Alves I; Willemsen AT; Dierckx RA; da Silva AM; Koole M
    J Cereb Blood Flow Metab; 2017 Mar; 37(3):866-876. PubMed ID: 27073203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Using a reference tissue model with spatial constraint to quantify [11C]Pittsburgh compound B PET for early diagnosis of Alzheimer's disease.
    Zhou Y; Resnick SM; Ye W; Fan H; Holt DP; Klunk WE; Mathis CA; Dannals R; Wong DF
    Neuroimage; 2007 Jun; 36(2):298-312. PubMed ID: 17449282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of TSPO overexpression in a rat model of local neuroinflammation induced by intracerebral injection of LPS by the use of [(18)F]DPA-714 PET.
    Ory D; Postnov A; Koole M; Celen S; de Laat B; Verbruggen A; Van Laere K; Bormans G; Casteels C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):163-172. PubMed ID: 26323575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Parametric imaging and quantitative analysis of the PET amyloid ligand [(18)F]flutemetamol.
    Heurling K; Buckley C; Van Laere K; Vandenberghe R; Lubberink M
    Neuroimage; 2015 Nov; 121():184-92. PubMed ID: 26209803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of dopamine transporter in human brain using PET with 18F-FE-PE2I.
    Sasaki T; Ito H; Kimura Y; Arakawa R; Takano H; Seki C; Kodaka F; Fujie S; Takahata K; Nogami T; Suzuki M; Fujiwara H; Takahashi H; Nakao R; Fukumura T; Varrone A; Halldin C; Nishikawa T; Suhara T
    J Nucl Med; 2012 Jul; 53(7):1065-73. PubMed ID: 22689927
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PET imaging of neurotransmission using direct parametric reconstruction.
    Petibon Y; Alpert NM; Ouyang J; Pizzagalli DA; Cusin C; Fava M; El Fakhri G; Normandin MD
    Neuroimage; 2020 Nov; 221():117154. PubMed ID: 32679252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.